JPMorgan Chase & Co. Sells 208,643 Shares of Koninklijke Philips (NYSE:PHG)

JPMorgan Chase & Co. lowered its holdings in shares of Koninklijke Philips (NYSE:PHG) by 84.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,086 shares of the technology company’s stock after selling 208,643 shares during the quarter. JPMorgan Chase & Co.’s holdings in Koninklijke Philips were worth $939,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of the business. Wilmington Savings Fund Society FSB bought a new stake in shares of Koninklijke Philips in the 3rd quarter worth about $54,000. Farther Finance Advisors LLC lifted its holdings in shares of Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after acquiring an additional 582 shares during the last quarter. Whipplewood Advisors LLC bought a new stake in shares of Koninklijke Philips in the 4th quarter worth about $55,000. Millstone Evans Group LLC bought a new stake in shares of Koninklijke Philips in the 4th quarter worth about $60,000. Finally, Allworth Financial LP lifted its holdings in shares of Koninklijke Philips by 24.9% in the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock worth $105,000 after acquiring an additional 797 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 0.9 %

Shares of PHG opened at $25.26 on Tuesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. The firm has a market capitalization of $23.74 billion, a price-to-earnings ratio of -30.07, a PEG ratio of 0.82 and a beta of 0.81. The company has a 50-day moving average of $25.09 and a 200 day moving average of $26.31. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $32.91.

Koninklijke Philips (NYSE:PHG) last posted its earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The business had revenue of $5.38 billion for the quarter, compared to analysts’ expectations of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. On average, research analysts expect that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently announced an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be given a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.

Analyst Ratings Changes

PHG has been the subject of several analyst reports. StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. Sanford C. Bernstein upgraded shares of Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Finally, BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.